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 Abstract    
Marfan syndrome is an autosomal dominant disorder of connective tissue with up to 25% of cases related to a 
spontaneous mutation. It has been associated with perinatal loss, preterm labor, and, potentially, a rupture of the 
maternal aortic arch. We present a case of a woman diagnosed with Marfan syndrome after a miscarriage of her 
first pregnancy. At the time of diagnosis she had mild aortic bulb dilation and insufficiency of the mitral and tricuspid 
valves. She underwent cardiosurgical correction, after which she had two uneventful pregnancies. 
This case suggests that preconceptional correction of valve defects in women with Marfan syndrome may 
decrease the risk of cardiac decompensation during future pregnancies. Additionally, close clinical follow up and 
the appropriate use of beta-adrenergic blockade may decrease the risk of aortic rupture, a significant risk factor for 
mortality in pregnant women.
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Introduction
Marfan	 syndrome	 (arachnodactyly),	 described	 for	 the	 first	
time	in	the	19th	century,	is	a	genetic	disorder	of	connective	tissue	
with	family	occurrence	of	75%	[1,	2].	 It	 is	caused	by	mutation	
of	a	gene	coding	fibrillin	(FBN1)	-	macromolecular	glycoprotein	
350kDa,	the	component	of	microfibrils,	 located	at	chromosome	
15q21.1	[2,	3,	4,	5].	This	mutation	 is	 found	in	90%	of	patients	
with	Marfan	syndrome,	and	the	risk	of	conveying	the	mutation	
to	 the	 fetus	 is	50%	(autosomal	dominant	 inheritance)	 [6,	7,	8].	
The	incidence	of	Marfan	syndrome	varies	from	1	in	3000	to	1	in	
20000	cases	[9,	10],	and	the		diagnosis	is	based	on	clinical	features	
with	 genetic	 confirmation.	On	 the	 clinical	 examination	we	 can	
found	multiorgan	disturbances	in	the	skeletal,	cardiovascular,	and	
ocular	systems.[1].	
McKusick	described	the	triad	of	symptoms	observed	in	this	
syndrome	[11].
1.	 Slim,	 asthenic	 posture,	 disproportionately	 long	
extremities	 in	 comparison	 to	 the	 trunk,	 arachnodactyly,	
chest	 deformation	 decreasing	 respiratory	 reserve	 and	
ventilation,	kyphoscoliosis,	and	flexibility	of	the	joints.	
2.	 Aortic	bulb	dilation	and/or	aortic	wall	dissection,	aortic	
valve	insufficiency,	prolapse	of	the	leaflet	of	mitral	valve	
and	mitral	insufficiency	[4,	12]	
3.	 Lens	ectopy	and	myopia	[7,	13]
Physical	 findings	 include	 striae	 distensae	 on	 thighs	 and	
buttocks,	 recurrent	 inguinal,	 umbilical	 or	 postsurgical	 hernias,	
and	 they	may	present	with	 spontaneous	pneumothorax	 [9,	 14].	
Reported	perinatal	complications	include:	spontaneous	abortion,	
isthmo-cervical	insufficiency,	preterm	labor,	intrauterine	growth	
restriction	(IUGR),	preterm	rupture	of	membranes	and	increased	
fetal	mortality	[7,	12,	15].
The	main	cause	of	 increased	mortality	 in	pregnant	women	
with	Marfan	syndrome	is	the	development	of	an	aortic	aneurysm	
of	Stanford	type	A,	its	dissection	and	rupture	[16,	17,	18,	19,	20].	
An	 increased	 cardiac	 contractility,	 heart	 rate,	 and	 vasorelaxing	
action	of	gender	hormones	are	the	predisposing	factors	for	these	
complications	[12,	18,	21,	22,	23,	24].
We	 describe	 a	 woman	 who	 was	 diagnosed	 with	 Marfan	
syndrome	 after	 her	 first	 pregnancy	 resulted	 in	 a	 miscarriage.	
At	 the	 time	of	 diagnosis	 she	 had	mild	 aortic	 bulb	 dilation	 and	
insufficiency	of	 the	mitral	and	 tricuspid	valves.	She	underwent	
cardiosurgical	 correction,	 after	 which	 she	 had	 two	 uneventful	
pregnancies.	
Case report
We	admitted	 to	 the	Clinic	 a	woman	 in	her	mid	20s,	 at	 22	
weeks	 gestation,	 because	 of	 spontaneous	 abortion	 in tractu 
due	 to	 isthmo-cervical	 insufficiency.	 During	 the	 miscarriage	 a	
brief,	self-limited	episode	of	atrial	fibrillation	was	observed	but	
without	any	symptoms	of	respiratory	or	cardiac	decompensation.	
We	 suspected	 the	 patient	 had	 been	 suffering	 from	 	 Marfan	
syndrome	 since	 childhood,	 however	 no	 disorders	 were	 found	
during	 annual	 medical	 check-ups	 at	 school.	 She	 had	 never	
undergone	 electrocardiography	 and	 echocardiography	 before.	
Slim	body	structure	 (weight	70kg,	height	184cm,	BMI	21.0kg/
m2,	 funnel-shaped	 chest	 and	 disproportionally	 long	 lower	
extremities	with	elongated	fingers	and	toes)	drew	our	attention.	
Striae	 distensae	 of	 the	 skin	 were	 present	 on	 the	 abdomen,	
buttocks	 and	 thighs.	 The	 echocardiogram	 revealed	mild	mitral	
regurgitation	 with	 parasystolic	 prolapse	 of	 anterior	 leaflet	 and	
mild	aortic	regurgitation	with	dilation	of	the	aortic	bulb.	In	1996	
the	diagnostic	criteria	of	Marfan	syndrome	were	established	and	
the	diagnosis	can	be	made	in	patients	who	have	four	of	the	eight	
major	criteria	[25].	
Our	 patient	 had	 five	 major	 criteria:	 1)	 decreased	 ratio	 of	
higher	to	lower	half	of	the	body,	2)	scoliosis	>20o,	3)	arachnoid	
toes,	 4)	 the	medial	 ankle	 being	 pushed	 out	 due	 to	 platypodia,	
and	5)	dilation	of	the	ascending	aorta.	Her	minor	criteria	were:	
prolapse	 of	 mitral	 leaflets,	 striae	 distensae	 not	 connected	 with	
fluctuation	of	body	weight	or	the	pregnancy.	
After	 the	 miscarriage,	 we	 referred	 the	 patient	 to	 the	
Department	of	Cardiosurgery.	Reconstruction	of	the	mitral	valve	
was	 not	 possible	 due	 to	 the	 atrophy	 of	 chordae	 tendinae,	 so	 it	
was	replaced	with	an	artificial	Carbomedix	31	valve,	and	similar	
chordae	atrophy	of	the	tricuspid	valve	was	corrected	by	the	De	
Vega	method.	After	the	operation	she	was	started	on	nadroparin	
(a	 low	molecular	weight	heparin)	and	later	acenocoumarol	was	
administered.	The	postoperative	left	ventricular	dimensions	were	
45mm	in	contraction	and	55mm	in	dilation	(N:	22-40mm	and	35-
57mm,	 respectively).	The	 left	ventricle	was	 thickened	with	 the	
interventricular	septum	measuring	15mm	in	dilation	(N:6-11mm).	
The	ejection	fraction	was	<50%.	The	mean	gradient	measured	at	
the	 artificial	mitral	 valve	was	5mmHg	and	 the	 estimated	valve	
areas	was	2.9cm2.	The	regurgitant	wave	at	the	tricuspid	valve	was	
small	(+).	The	aorta	was	normal.	
An	 ultrasound	 performed	 two	 years	 later	 showed	
concentrically	thickened	muscle	of	the	left	ventricle	(11/19mm)	
 Streszczenie:
Zespół Marfana jest chorobą tkanki łącznej dziedziczoną w sposób autosomalny dominujący. W ok. 25 % przy-
padków dochodzi do spontanicznej mutacji. Zespół ten jest związany z utratami ciąż, porodem przedwczesnym 
oraz niesie potencjalne ryzyko pęknięcia łuku aorty u matki. W pracy opisano kobietę, u której rozpoznano zespół 
Marfana po poronieniu w pierwszej ciąży. W momencie rozpoznania miała łagodne poszerzenie aorty oraz niedo-
mykalność zastawki mitralnej i trójdzielnej. Po pierwszej ciąży u pacjentki wykonano operację kardiochirurgiczną, po 
której przebyła bez powikłań dwie kolejne ciąże. 
Przypadek ten sugeruje, iż przedkoncepcyjna korekcja kardiochirurgiczna może zmniejszyć ryzyko powikłań kardio-
logicznych podczas ciąży u kobiet z zespołem Marfana. Dodatkowo właściwe użycie beta blokerów może zmniej-
szyć ryzyko pęknięcia aorty, które jest przyczyną wysokiej śmiertelności kobiet z zespołem Marfana podczas ciąży.
 Słowa kluczowe: zespół Marfana / utraty ciąż / poród przedwczesny /
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with	normal	size	and	contractility.	The	peak	gradient	across	the	
artificial	mitral	valve	was	8.3mmHg	with	a	mean	of	4.1mmHg.	
The	aortic	diameter	was	33mm.
Three	years	after	 the	 surgery	 the	patient	became	pregnant.	
Acenocoumarol	 was	 changed	 to	 nadroparin,	 3800	 IU	
subcutaneously/day.	At	23	weeks	gestation	we	applied	a	cervical	
suture	using	the	Mc	Donald	technique	because	of	isthmo-cervical	
insufficiency.	 The	 patient	 did	 not	 develop	 any	 hemodynamic	
disturbances	 during	 the	 pregnancy.	 Upon	 recommendation,	
she	 underwent	 multiple	 check-ups.	 Blood	 pressure	 and	 heart	
rate	were	normal.	The	measurement	 of	 the	 aortic	 bulb	 showed	
dilation	up	to	40mm.	At	37	weeks	gestation	she	delivered	a	male	
newborn	(weight	2550g,	length	49cm,	5-minute	Apgar	score	of	
8)	by	Cesarean	section	(patient	preference).	The	follow	up	of	the	
baby	 revealed	 frequent	 upper	 respiratory	 tract	 infections	 and	 a	
heart	murmur.	 Prolapse	 of	 the	mitral	 and	 tricuspid	 valves	was	
diagnosed	 in	 the	second	year	of	his	 life,	and	Marfan	syndrome	
was	diagnosed	when	the	child	was	6	years	old.	
Twelve	years	after	the	surgery	we	again	admitted	the	patient	
to	the	High-risk	Pregnancy	Department	at	37	weeks	gestation.	She	
was	receiving	metoprolol	(50	mg	per	day)	and	alpha-methyldopa	
(750	mg	per	day)	because	of	gestational	hypertension,	diagnosed	
at	 20	 weeks	 gestation.	 The	 administration	 of	 3800	 IU	 of	
nadroparin	was	also	continued.	Until	the	time	of	hospitalization,	
the	 patient	 was	 followed	 in	 the	 outpatient	 clinic	 without	 any	
perinatal	or	cardiac	complications.	
 Antenatal ultrasounds revealed normal body weight 
(40-50	 percentile	 of	 growth	 at	 30	 and	 34	 gestational	 weeks),	
biophysical	 profile	 and	 Doppler	 parameters	 of	 placental	 flow.	
Fetal	echocardiography	showed	normal	structure	and	pressures.	
Physical	 examination	 and	 echocardiography	 of	 the	 mother	
detected	 only	 persistent	 mild	 dilation	 of	 the	 aortic	 bulb	 up	 to	
42mm.	The	results	of	the	laboratory	tests	performed	at	37	weeks	
of	gestation	were	as	follows:	Hb	13.3	g/dl,	WBC	5.7	K/ul,	PLT	
184	K/ul,	creatinine	0.54mg/dl,	urea	17	mg/dl,	total	protein	5.84	
g/dl,	total	bilirubin	0.86	mg/dl,	Na+	138	mmol/l,	K+	4.31	mmol/l,	
INR	0.9.	
She	 delivered	 at	 38	 weeks	 by	 Cesarean	 section	 (patient	
preference)	 a	 male	 newborn	 (weight	 3450g,	 length	 57cm,	
5-minute	Apgar	score	of	9).	ECG	performed	after	the	Cesarean	
section	revealed	a	few	ectopic	ventricular	beats.	The	patient	was	
discharged	on	the	5th	postpartum	day	in	good	general	condition.	
Outpatient	 check-ups	 showed	 normal	 post-operative	 recovery.	
Pediatric	 evaluation	 of	 the	 baby	 revealed	 normal	 undisturbed	
development	consistent	with	age.	No	clinical	symptoms	of	Marfan	
syndrome	 were	 apparent.	 A	 postpartum	 echocardiographic	
evaluation	 revealed	 “lazy”	 function	 of	 the	 left	 ventricle	 with	
EF	 55%,	 characteristic	 for	 treatment	 with	 beta-blockers.	 The	
diameter	of	the	aortic	bulb	was	40mm	with	preserved	function	of	
the	artificial	valve.		
Comment
Pregnant	women	with	cardiac	diseases	are	at	risk	of	pregnancy	
loss,	IUGR	and	serious	circulatory	insufficiency	leading	even	to	
maternal	 death.	 [21,26,27,28].	 Presbitero	 et	 al.,	 [6]	 are	 of	 the	
opinion	 that	 female	 patients	 with	 severe	 ostial	 aortic	 stenosis,	
Eisenmenger	 syndrome	 and	Marfan	 syndrome	with	 dilation	 of	
the	 aortic	bulb	 should	not	become	pregnant.	Marfan	 syndrome	
may	 be	 associated	 with	 considerable	 mortality	 for	 pregnant	
women,	especially	in	rare	cases	of	aortic	arch	dissection	or	aortic	
rupture	[13,	22,	27,	29].	Even	with	the	lack	of	cardio-circulatory	
problems	before	conception,	the	pregnancy	increases	the	risk	of	
aortic	root	dilation	[2].	The	preconceptual	diameter	of	the	aorta	of	
>45mm	is	regarded	as	an	important	prognostic	factor	and,	together	
with	 other	 cardiac	 abnormalities,	may	 be	 a	 contraindication	 to	
pregnancy.	 [2,4].	 Clinicians	 should	 consider	 obtaining	 cardiac	
magnetic	 resonance	 (MR)	 angiography	 before	 pregnancy	 to	
evaluate	the	aorta,	and,	once	the	patient	is	pregnant,	they	should	
either	 repeat	 the	MR	study	or	obtain	serial	echocardiograms	 to	
monitor	the	progression	of	the	aortic	root	dilation	[12].	Various	
reason	 for	 the	 frequent	 occurrence	 of	 aortic	 dissection	 during	
pregnancy	include	the	hyperkinetic	and	hypervolemic	circulation	
[7],	 suppressed	 collagen	 and	 elastin	 accumulation	 in	 the	 aorta,	
along	with	 progesterone-mediated	 acceleration	 of	 non-collagen	
protein	 accumulation	 [30].	Another	 reasons	 may	 be	 increased	
relaxin	concentration	during	the	pregnancy	which	is	responsible	
for	aortic	wall	 remodeling	 [12].	Finally,	a	 theoretical	cause	 for	
additional	 stress	 on	 the	 proximal	 aorta	 is	 the	 pressure	 exerted	
by	the	gravid	uterus	on	the	distal	aorta	causing	resistance	to	the	
flow	of	blood	from	the	proximal	aorta.	A	single	case	report	of	a	
Marfan	patient	suggested	that	after	delivery,	the	decrease	in	the	
uterine	size	could	favor	rapid	flow	acceleration	in	the	abdominal	
segment	of	the	aorta	and	could	be	the	cause	of	the	development	of	
abdominal	aortic	aneurism.	However,	it	is	likely	that	the	severity	
of	 her	 Marfan	 syndrome	 explains	 her	 aortic	 disorders	 as	 she	
later	developed	proximal	aortic	dilation	unrelated	to	pregnancy.
[4]	 	 Medical	 treatment	 of	 an	 acute	 aortic	 dissection	 in	 non-
pregnant	patients	includes	intravenous	administration	of	sodium	
nitroprusside	 and	 beta-adrenergic	 blocking	 agents	 in	 order	 to	
control	 blood	 pressure,	 decrease	 left	 ventricular	 contractility,	
and	 decrease	 shear	 forces	 on	 the	 aorta	 [14].	 However,	 during	
pregnancy	the	use	of	sodium	nitroprusside	is	contraindicated	as	
it	may	cause	fetal	intoxication	with	thiocyanate,	therefore	beta-
adrenergic	 blocking	 agents	 or	 hydralazine	 should	 be	 used.	 [7,	
14].	[2].	Beta-blockers	are	not	teratogenic	and	they	reduce	stroke	
volume	 and	heart	 rate	 [4]	 that	may	decrease	 the	 percentage	of	
aortic	aneurysms	and	dissection	[31].	Side	effects	of	their	usage	
may	include	a	decrease	of	newborn	birth	weight,	but	this	has	been	
observed	 to	 be	 a	 risk	 of	Marfan	 syndrome	without	medication	
exposure	[12].	Aortic	dilation	is	connected	with	extremely	high	
mortality,	 so	 early	 diagnosis	 and	 surgical	 treatment	 of	 aortic	
dilation	 is	 crucial	 for	 the	 survival	 of	 both,	 the	mother	 and	 the	
fetus	 [27].	 Mortality	 can	 even	 reach	 25%	 during	 the	 first	 24	
hours	 up	 to	 75%	 in	 two-weeks	 [17].	 In	 1986	Gott	 et	 al.,	 [29]	
demonstrated	85%	5-year	survival	in	a	population	of	50	women	
with	Marfan	syndrome	after	ascending	aorta	graft.	While	 those	
authors	 recommended	 surgery	 when	 the	 aortic	 bulb	 diameter	
was	>	60mm,	 later	 studies	by	Murgatroyd	et	 al.,	 [32]	 revealed	
that	 aortic	 dissection	 can	 develop	 with	 the	 diameter	 of	 only	
51±13mm.	Bearing	that	in	mind,	current	recommendations	are	to	
perform	corrective	surgery	for	Marfan	patients	with	an	aortic	root	
>45mm,	or	 if	 serial	 echocardiographic	 evaluations	detect	 rapid	
progression	of	the	aortic	root	enlargement,	particularly	in	patients	
with	positive	family	history	of	aorta	dissection	or	in	those	who	
are	planning	pregnancy	[8,	15,	21,	33].		In	the	absence	of	obstetric	
indications,	there	is	no	data	to	suggest	that	in	cases	without	aortic	
dilation	 vaginal	 labor	 is	 contraindicated	 [34].	Even	with	 aortic	
dilation,	 similarly	 to	 patients	 with	 severe	 mitral	 stenosis,	 it	 is	
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reasonable	to	attempt	a	vaginal	delivery	and	avoid	the	increased	
risks	of	 infection,	 thromboembolism,	and	postoperative	cardiac	
stresses	associated	with	the	Cesarean	section	[12,	14,	34].
Due	 to	 retrospective	 reports	 and	 high	 mortality	 reported	
among	 pregnant	 Marfan	 patients	 with	 aortic	 root	 dilation	
>45	mm,	many	 authors	 state	 that	 high-risk	 patients	with	more	
significant	 cardiac/aortic	 structural	 abnormalities,	 such	 as	
dilation	 of	 the	 aortic	 bulb	 beyond	 45mm,	 aortic	 dissection	 or	
significant	valve	abnormalities,	should	be	delivered	by	Cesarean	
section.	The	theory	is	that	by	avoiding	the	pushing	during	labor	
we	can	diminish	hemodynamic	changes	and	stresses.	However,	it	
is	important	to	understand	that	the	postoperative	fluid	shifts	and	
stresses	to	the	heart	are	greater	after	a	Cesarean	section	than	after	
vaginal	delivery	[2,	6].	This	is	a	controversial	topic,	but	it	seems	
reasonable	 to	 consider	 vaginal	 delivery,	 as	 discussed	 above,	
with	aggressive	control	of	pain,	blood	pressure,	 and	heart	 rate.	
Antibiotic	prophylaxis	has	to	be	implemented	for	prevention	of	
endocarditis	according	 to	 the	 recommendation	of	 the	European	
Society	 of	 Cardiology.	 Because	 of	 the	 low	 risk	 of	 bacteremia	
with	 organisms	 likely	 to	 cause	 endovascular	 infection,	 the	
recent	guidelines	 from	 the	American	College	of	Cardiology	no	
longer	recommend	bacterial	endocarditis	for	vaginal	delivery	or	
Cesarean	section	[35].	Attention	should	be	drawn	to	the	fact	that	
our	patient	had	only	slight	aortic	bulb	dilation	without	symptoms	
of	dissection	or	aortic	valve	defect.	Similarly,	her	elder	son	was	
diagnosed	with	prolapse	of	mitral	and	tricuspid	leaflets.	In	1989,	
Glesby	 and	 Pyeritz	 suggested	 the	 use	 of	 an	 acronym	 MASS	
phenotype	(mitral valve, aorta, skeleton, skin)	for	patients	with	
small	 criteria	of	Marfan	Syndrome:	moderate	dilation	of	aortic	
bulb,	mitral	insufficiency,	alterations	in	osteoarticular	system	and	
skin	disorders	[36].	
It is worth noting that although she had severe mitral and 
tricuspid	 abnormalities	 during	 the	 first	 pregnancy,	 she	 did	
not	 present	 with	 any	 cardiac	 symptoms.	 In	 fact,	 the	 cardiac	
abnormalities	we	detected	after	the	miscarriage	when	her	clinical	
team	initiated	an	evaluation	after	noting	a	 typical	Marfan	body	
habitus.	 While	 one	 can	 postulate	 that	 cardiac	 abnormalities	
contributed	to	her	miscarriage,	in	the	absence	of	objective	signs	
of	 cardiac	 decompensation,	 cervical	 insufficiency	 seems	 to	
have	been	a	more	likely	cause.	Cardio	surgical	correction	most	
probably	allowed	her	to	tolerate	her	two	subsequent	pregnancies	
without	further	cardiac	decompensation	or	damage.	The	presented	
case	 is	 evidence	 that	 preconceptual	 hemodynamically	 effective	
correction	of	the	valve	defects	in	women	with	Marfan	syndrome,	
together	with	the	appropriate	use	of	beta-adrenergic	blockade	for	
concomitant	aortic	dilation,	make	conception	and	term	delivery	
of	consecutive	pregnancies	possible.
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